What side effects are patients asking about?
Patients taking semaglutide, such as Ozempic, have raised concern about experiencing dizziness as a side effect. Research has shown that this medication may increase the risk of dizziness and other adverse reactions.
Why might patients feel dizzy on semaglutide?
Semaglutide works by mimicking the effects of the incretin hormone glucagon-like peptide-1 (GLP-1), which helps regulate blood sugar levels. Studies indicate that the drug's mechanism of action may cause temporary hypoglycemia, nausea, dizziness, and other gastrointestinal side effects [1].
How common is dizziness on semaglutide?
According to clinical trials, dizziness was identified as a common adverse event among patients taking semaglutide. Specifically, in the STEP-1 trial, which assessed the safety and efficacy of semaglutide in patients with type 2 diabetes, dizziness was reported by 4.7% of patients in the drug group compared to 2.3% in the placebo group [2].
What should patients do if they experience dizziness on semaglutide?
If you are taking semaglutide and experience dizziness, it is essential to consult your healthcare provider. They will help you manage the side effects and determine the cause of your dizziness. In some cases, dizziness may be alleviated by adjusting the dosage or switching to another medication.
Are there biosimilars to semaglutide that have a different side effect profile?
While there are no biosimilars to semaglutide on the market yet, a number of companies are developing them. The regulatory pathways for biosimilars will likely include a comparison of the safety and efficacy of these new medications versus the original semaglutide, including assessing the incidence of dizziness and other side effects.
Sources:
[1] FDA: Semaglutide injection, for intravenous use, for Type 2 Diabetes Mellitus, retrieved from https://www.accessdata.fda.gov/drugsatfdadocs/nda/2021/213471semaglutide_toc.cfm
[2] Novo Nordisk: ClinicalTrials.gov: NCT01243419, retrieved from https://clinicaltrials.gov/ct2/show/NCT01243419
[3] DrugPatentWatch.com: Semaglutide, retrieved from https://www.drugpatentwatch.com/product/semaglutide